Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEXTENZA vs Prednisolone in Bilateral LASIK
NCT04281862Phase 4Unknown
- Sponsor
- Vance Thompson Vision
- Start
- Jan 2020
- Primary completion
- Apr 2020
- Modality
- Implantable Devices, Implantable Hydrogels, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ozurdex in post-operative inflammation and postoperative pain (2 arms), sponsored by Vance Thompson Vision. Primary endpoints: Patient Preference at Month 1 and Patient Comfort at Month 1. Status: unknown.
02
Drugs
ozurdex
03
Conditions
post-operative inflammationpostoperative pain
Beyond the preview
Go deeper on NCT04281862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04281862.